TCR2 Therapeutics Inc.(TCRR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TCRR TCR2 Therapeutics Inc.

停牌 12-20 14:42:20 EST

1.48

+0.00

0.00%

最高1.48	最低1.48	成交量0.00
今开1.48	昨收1.48	日振幅0.00%
总市值5,811万	流通市值3,960万	总股本3,926万
成交额596.81万	换手率0.00%	流通股本2,675万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TCRR","market":"US","secType":"STK","nameCN":"TCR2 Therapeutics Inc.","latestPrice":1.48,"timestamp":1685563200000,"preClose":1.48,"halted":3,"volume":0,"delay":0,"floatShares":26754523,"shares":39261745,"eps":-4.203032,"marketStatus":"停牌","marketStatusCode":2,"change":0,"latestTime":"12-20 14:42:20 EST","open":1.48,"high":1.48,"low":1.48,"amount":5968093.435236,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.203032,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734728400000},"adr":0,"listingDate":1550120400000,"adjPreClose":1.48,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/TCRR/tweets","defaultTab":"tweets","newsList":[{"id":"2340021429","title":"Tcr2 Therapeutics Inc盘中异动 临近收盘快速下跌5.73%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2340021429","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2340021429?lang=zh_cn&edition=full","pubTime":"2023-06-01 04:00","pubTimestamp":1685563256,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202306010400568366527a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202306010400568366527a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRR"],"gpt_icon":0},{"id":"2338163170","title":"Tcr2 Therapeutics Inc盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2338163170","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2338163170?lang=zh_cn&edition=full","pubTime":"2023-05-26 21:49","pubTimestamp":1685108992,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052621495282cc4443&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052621495282cc4443&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRR"],"gpt_icon":0},{"id":"2325090953","title":"Tcr2 Therapeutics Inc盘中异动 大幅上涨5.24%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2325090953","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2325090953?lang=zh_cn&edition=full","pubTime":"2023-04-06 21:46","pubTimestamp":1680788809,"startTime":"0","endTime":"0","summary":"北京时间2023年04月06日21时46分，Tcr2 Therapeutics Inc股票出现异动，股价快速上涨5.24%。截至发稿，该股报1.51美元/股，成交量2.2432万股，换手率0.06%，振幅4.20%。Tcr2 Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.66%。Tcr2 Therapeutics Inc公司简介：TCR2 Therapeutics Inc是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230406214650846e6ff4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230406214650846e6ff4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRR"],"gpt_icon":0},{"id":"2322325624","title":"Tcr2 Therapeutics Inc2022财年实现净利润-1.52亿美元，同比减少52.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2322325624","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2322325624?lang=zh_cn&edition=full","pubTime":"2023-03-28 18:28","pubTimestamp":1679999304,"startTime":"0","endTime":"0","summary":"12月31日，Tcr2 Therapeutics Inc公布财报，公告显示公司2022财年净利润为-1.52亿美元，同比减少52.29%；其中营业收入为0.00美元，每股基本收益为-3.93美元。从资产负债表来看，Tcr2 Therapeutics Inc总负债67.38百万美元，其中短期债务21.83百万美元，资产负债比为0.04，流动比率为0.03。机构评级：截至2022年12月31日，当前有6家机构对Tcr2 Therapeutics Inc目标价做出预测，其中目标均价为2.23美元，其中最低目标价为1.68美元，最高目标价为3.00美元。公司简介：TCR2 Therapeutics Inc是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230328182856846e157e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230328182856846e157e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRR"],"gpt_icon":0},{"id":"2322141190","title":"Tcr2 Therapeutics Inc盘中异动 下午盘股价大涨5.63%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2322141190","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2322141190?lang=zh_cn&edition=full","pubTime":"2023-03-25 02:34","pubTimestamp":1679682875,"startTime":"0","endTime":"0","summary":"北京时间2023年03月25日02时34分，Tcr2 Therapeutics Inc股票出现波动，股价急速拉升5.63%。截至发稿，该股报1.50美元/股，成交量17.1298万股，换手率0.44%，振幅9.15%。Tcr2 Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.76%。Tcr2 Therapeutics Inc公司简介：TCR2 Therapeutics Inc是一家临床阶段的细胞治疗公司。消息层面，截至02时34分，Tcr2 Therapeutics Inc股票正面舆情新闻比例20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230325023435835676db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230325023435835676db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRR","BK4139"],"gpt_icon":0},{"id":"2317917606","title":"Tcr2 Therapeutics Inc股价拉升28.10% 市值涨1683.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2317917606","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2317917606?lang=zh_cn&edition=full","pubTime":"2023-03-06 22:30","pubTimestamp":1678113005,"startTime":"0","endTime":"0","summary":"北京时间2023年03月06日22时30分，Tcr2 Therapeutics Inc股票出现波动，股价快速上涨28.10%。截至发稿，该股报1.55美元/股，成交量478.427万股，换手率12.38%，振幅0.00%。Tcr2 Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.20%。其相关个股中，Bridgebio Pharma Inc、Tcr2 Therapeutics Inc、Tyra Biosciences Inc涨幅较大，Unicycive Therapeutics Inc、Tcr2 Therapeutics Inc、Entera Bio Ltd较为活跃，换手率分别为138.87%、12.38%、8.16%，振幅较大的相关个股有Adial Pharmaceuticals Inc、Orchard Therapeutics Plc、Mymd Pharmaceuticals Inc，振幅分别为16.67%、15.79%、7.46%。Tcr2 Therapeutics Inc公司简介：TCR2 Therapeutics Inc是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230306223006846dc015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230306223006846dc015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRR"],"gpt_icon":0},{"id":"2316396350","title":"Tcr2 Therapeutics Inc盘中异动 快速下挫5.47%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2316396350","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2316396350?lang=zh_cn&edition=full","pubTime":"2023-03-03 01:26","pubTimestamp":1677778010,"startTime":"0","endTime":"0","summary":"北京时间2023年03月03日01时26分，Tcr2 Therapeutics Inc股票出现异动，股价快速下挫5.47%。截至发稿，该股报1.21美元/股，成交量2.5648万股，换手率0.07%，振幅6.18%。Tcr2 Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.24%。Tcr2 Therapeutics Inc公司简介：TCR2 Therapeutics Inc是一家临床阶段的细胞治疗公司。消息层面，截至01时26分，Tcr2 Therapeutics Inc股票正面舆情新闻比例75%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230303012651846db77d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230303012651846db77d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRR","BK4139"],"gpt_icon":0},{"id":"2310631668","title":"Tcr2 Therapeutics Inc盘中异动 早盘快速拉升14.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2310631668","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2310631668?lang=zh_cn&edition=full","pubTime":"2023-02-09 22:36","pubTimestamp":1675953360,"startTime":"0","endTime":"0","summary":"北京时间2023年02月09日22时36分，Tcr2 Therapeutics Inc股票出现波动，股价快速上涨14.84%。Tcr2 Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Seastar Medical Holding Corp C/Wts 28/10/2027 、Organovo Hldgs Inc、Xenetic Biosciences Inc C/Wts 19/07/2024 涨幅较大，Kiora Pharmaceuticals Inc、Seastar Medical Holding Corp、Revelation Biosciences Inc较为活跃，换手率分别为133.07%、48.71%、36.02%，振幅较大的相关个股有Xenetic Biosciences Inc C/Wts 19/07/2024 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Apexigen Inc C/Wts 29/07/2027 ，振幅分别为52.17%、32.12%、27.59%。Tcr2 Therapeutics Inc公司简介：TCR2 Therapeutics Inc是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230209223600834e01e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230209223600834e01e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCRR","BK4139"],"gpt_icon":0},{"id":"2310542488","title":"Tcr2 Therapeutics Inc盘中异动 股价大跌5.07%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2310542488","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2310542488?lang=zh_cn&edition=full","pubTime":"2023-02-09 02:31","pubTimestamp":1675881100,"startTime":"0","endTime":"0","summary":"北京时间2023年02月09日02时31分，Tcr2 Therapeutics Inc股票出现异动，股价大幅下挫5.07%。截至发稿，该股报1.31美元/股，成交量4.4972万股，换手率0.12%，振幅2.16%。Tcr2 Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.23%。其相关个股中，Creative Medical Tech Holding Inc、Avrobio Inc、Kiora Pharmaceuticals Inc涨幅较大，Kiora Pharmaceuticals Inc、Creative Medical Tech Holding Inc、Hoth Therapeutics Inc较为活跃，换手率分别为1031.50%、875.87%、480.55%，振幅较大的相关个股有Avrobio Inc、Creative Medical Tech Holding Inc、Kiora Pharmaceuticals Inc，振幅分别为107.75%、75.39%、56.04%。Tcr2 Therapeutics Inc公司简介：TCR2 Therapeutics Inc是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230209023141834dc843&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230209023141834dc843&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRR"],"gpt_icon":0},{"id":"2300450984","title":"Tcr2 Therapeutics Inc盘中异动 股价大涨5.13%报1.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2300450984","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2300450984?lang=zh_cn&edition=full","pubTime":"2023-01-03 23:20","pubTimestamp":1672759230,"startTime":"0","endTime":"0","summary":"北京时间2023年01月03日23时20分，Tcr2 Therapeutics Inc股票出现波动，股价急速上涨5.13%。截至发稿，该股报1.050美元/股，成交量4846股，换手率0.01%，振幅4.39%。Tcr2 Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.02%。Tcr2 Therapeutics Inc公司简介：TCR2 Therapeutics Inc是一家临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023010323203183470ad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023010323203183470ad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCRR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tcr2.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tcr2 Therapeutics Inc.于2015年5月根据特拉华州法律以TCR2，Inc.的名义注册成立,2016年11月14日，他们更名为TCR2 Therapeutics Inc.。他们是一家研究创新型的免疫治疗方法的公司，为患有癌症的患者开发下一代新型T细胞疗法。他们专有的TCR Fusion Construct T细胞（TRuC-T细胞）通过利用整个T细胞受体（TCR）信号传导复合物特异性识别和杀死癌细胞，他们认为这对于T细胞疗法对实体瘤患者有效至关重要。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.007092},{"month":2,"riseRate":0.25,"avgChangeRate":-0.122229},{"month":3,"riseRate":0.4,"avgChangeRate":-0.096292},{"month":4,"riseRate":0.6,"avgChangeRate":0.03272},{"month":5,"riseRate":0.4,"avgChangeRate":-0.053669},{"month":6,"riseRate":0.4,"avgChangeRate":0.116342},{"month":7,"riseRate":0.75,"avgChangeRate":0.007769},{"month":8,"riseRate":0.75,"avgChangeRate":0.123881},{"month":9,"riseRate":0.25,"avgChangeRate":-0.233594},{"month":10,"riseRate":0,"avgChangeRate":-0.148112},{"month":11,"riseRate":0.5,"avgChangeRate":0.103333},{"month":12,"riseRate":0.25,"avgChangeRate":-0.091609}],"exchange":"NASDAQ","name":"TCR2 Therapeutics Inc.","nameEN":"TCR2 Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TCR2 Therapeutics Inc.(TCRR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TCR2 Therapeutics Inc.(TCRR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TCR2 Therapeutics Inc.,TCRR,TCR2 Therapeutics Inc.股票,TCR2 Therapeutics Inc.股票老虎,TCR2 Therapeutics Inc.股票老虎国际,TCR2 Therapeutics Inc.行情,TCR2 Therapeutics Inc.股票行情,TCR2 Therapeutics Inc.股价,TCR2 Therapeutics Inc.股市,TCR2 Therapeutics Inc.股票价格,TCR2 Therapeutics Inc.股票交易,TCR2 Therapeutics Inc.股票购买,TCR2 Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TCR2 Therapeutics Inc.(TCRR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TCR2 Therapeutics Inc.(TCRR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}